Synbiotics Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 10-07-2024
- Paid Up Capital ₹ 8.89 Cr
as on 10-07-2024
- Company Age 64 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.65 Cr
as on 10-07-2024
- Satisfied Charges ₹ 23.48 Cr
as on 10-07-2024
- Revenue 42.64%
(FY 2021)
- Profit 28.90%
(FY 2021)
- Ebitda 145.10%
(FY 2021)
- Net Worth 5.74%
(FY 2021)
- Total Assets -0.24%
(FY 2021)
About Synbiotics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 8.89 Cr.
The company currently has active open charges totaling ₹15.65 Cr. The company has closed loans amounting to ₹23.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mohal Sarabhai, Mayurkumar Swadia, Anurag Mehta, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GJ1960PLC000992
- Company No.
000992
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Oct 1960
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Synbiotics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Dhru  | Director | 28-Jun-2004 | Current |
| Mohal Sarabhai | Director | 30-Mar-2000 | Current |
| Mayurkumar Swadia | Director | 09-Nov-2020 | Current |
| Anurag Mehta | Whole-Time Director | 11-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Synbiotics.
Synbiotics Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 42.64% increase. The company also saw a substantial improvement in profitability, with a 28.9% increase in profit. The company's net worth moved up by a moderate rise of 5.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synbiotics?
In 2022, Synbiotics had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Sarabhai Chemicals (India) Private LimitedActive 20 years 10 monthsMohal Sarabhai is a mutual person
Sarabhai M. Chemicals LimitedActive 23 years 11 monthsMohal Sarabhai and Rajiv Dhru are mutual person
Asence Pharma Private LimitedActive 20 years 5 daysMohal Sarabhai and Mayurkumar Swadia are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 06 Dec 2023 | ₹2.00 Cr | Open |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 17 Oct 2022 | ₹1.80 Cr | Open |
The Kalupur Commercial Co-Operative Bank Ltd. Creation Date: 22 Dec 2015 | ₹5.00 M | Open |
How Many Employees Work at Synbiotics?
Synbiotics has a workforce of 56 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synbiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synbiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
